CTKB Cytek Biosciences
- 5.670
- +0.020+0.35%
- 5.670
- 0.0000.00%
Cytek Biosciences News
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Barnett Valerie
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Jiang Wenbin
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Christopher
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Busque Philippe
Cytek Biosciences | 10-Q: Q2 2024 Earnings Report
Cytek Biosciences | 8-K: Cytek Biosciences Reports Second Quarter 2024 Financial Results
Cytek Biosciences | 8-K: Current report
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 3: Initial statement of beneficial ownership of securities-Director Holder Michael
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ball Jack
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director NEFF DEBORAH J
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Imper Vera
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Director HARDISON DON M
Cytek Biosciences | SD: Specialized disclosure report
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Poirson Allen
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Yan Ming
Cytek Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Williams Paul Christopher
Analysis
Price Target
No Data
